Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $1.04 Million - $1.27 Million
124,400 Added 272.81%
170,000 $1.66 Million
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $155,430 - $181,492
-15,700 Reduced 25.61%
45,600 $451,000
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $633,842 - $785,253
61,300 New
61,300 $707,000
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $217,833 - $279,312
-25,300 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$8.57 - $12.69 $98,555 - $145,935
-11,500 Reduced 31.25%
25,300 $228,000
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $457,967 - $739,968
-56,400 Reduced 60.52%
36,800 $454,000
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $3.01 Million - $6.04 Million
-449,300 Reduced 82.82%
93,200 $837,000
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $3.04 Million - $5 Million
466,300 Added 611.94%
542,500 $5.32 Million
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $472,472 - $736,320
-76,700 Reduced 50.16%
76,200 $524,000
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $1 Million - $1.94 Million
123,700 Added 423.63%
152,900 $1.41 Million
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $454,936 - $584,292
29,200 New
29,200 $458,000
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $917,711 - $1.5 Million
-62,900 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $450,684 - $548,910
-21,400 Reduced 25.39%
62,900 $1.36 Million
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $2.46 Million - $3.62 Million
-146,400 Reduced 63.46%
84,300 $2.05 Million
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $2.59 Million - $3.42 Million
155,100 Added 205.16%
230,700 $3.94 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $664,816 - $1.13 Million
59,200 Added 360.98%
75,600 $1.43 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $252,724 - $527,588
16,400
16,400 $289,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.